Distinct brain perfusion pattern associated with CSF biomarkers profile in primary progressive aphasia

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 7, 2012, Pages 695-698

  Kas, Aurélie ^a,b   Uspenskaya, Olga ^a   Lamari, Foudil ^a   De Souza, Leonardo Cruz ^a,c   Habert, Marie Odile ^a,b   Dubois, Bruno ^a,c   Teichmann, Marc ^a,c   Sarazin, Marie ^a,c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN PERFUSION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MARKER; FEMALE; HUMAN; LEFT HEMISPHERE; LUMBAR PUNCTURE; MALE; PARIETAL CORTEX; PHENOTYPE; PREFRONTAL CORTEX; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUPRASYLVIAN GYRUS; TEMPORAL CORTEX;

EID: 84861898063     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-302165     Document Type: Article

References (14)

1. Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology 2011;76:1006-14.
2. Deramecourt V, Lebert F, Debachy B, et al. Prediction of pathology in primary progressive language and speech disorders. Neurology 2010;74:42-9.
3. Rabinovici GD, Jagust WJ, Furst AJ, et al. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 2008;64:388-401.
4. Leyton CE, Villemagne VL, Savage S, et al. Subtypes of progressive aphasia: application of the international consensus criteria and validation using {beta}-amyloid imaging. Brain 2011;134:3030-43.
5. de Souza LC, Lamari F, Belliard S, et al. Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias. J Neurol Neurosurg Psychiatry 2011;82:240-6.
6. Mesulam M. Primary progressive aphasia. Ann Neurol 2001;49:425-32. (Pubitemid 32281326)
7. Hodges JR, Patterson K, Oxbury S, et al. Semantic dementia: progressive fluent aphasia with temporal lobe atrophy. Brain 1992;115:1783-806. (Pubitemid 23054865)
8. Visser PJ, Verhey F, Knol DL, et al. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol 2009;8:619-27.
9. Koric L, Felician O, Ceccaldi M. Use of CSF biomarkers in the diagnosis of Alzheimer's disease in clinical practice. Rev Neurol (Paris) 2011;167:474-84.
10. Kas A, de Souza LC, Samri D, et al. Neural correlates of cognitive impairment in posterior cortical atrophy. Brain 2011;134:1464-78.
11. Gorno-Tempini ML, Dronkers NF, Rankin KP, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 2004;55:335-46. (Pubitemid 38269585)
12. Mesulam M, Wieneke C, Rogalski E, et al. Quantitative template for subtyping primary progressive aphasia. Arch Neurol 2009;66:1545-51.
13. Dubois B, Feldman HH, Jacova C, et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol 2010;9:1118-27.
14. Knibb JA, Xuereb JH, Patterson K, et al. Clinical and pathological characterization of progressive aphasia. Ann Neurol 2006;59:156-65. (Pubitemid 43042882)